Skin disorders associated with obesity in children and adolescents: A population-based study

Pediatric Dermatology

Volumn 31, Issue 2, 2014, Pages 183-190

  Mirmirani, Paradi ^a,b,c   Carpenter, Diane M ^d  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BODY MASS; CHILD; DISEASE ASSOCIATION; FEMALE; HIDRADENITIS; HUMAN; HYPERANDROGENISM; HYPERHIDROSIS; INFLAMMATION; INSULIN RESISTANCE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SKIN DISEASE; STRIA; VEIN INSUFFICIENCY; VIRUS INFECTION; EPIDEMIOLOGY; RETROSPECTIVE STUDY; SKIN DISEASES; UNITED STATES;

ADOLESCENT; CALIFORNIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; OBESITY; PREVALENCE; RETROSPECTIVE STUDIES; SKIN DISEASES; UNITED STATES;

EID: 84895923705     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12271     Document Type: Article

References (26)

1. Ogden CL, Carroll MD, Flegal KM,. High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008; 299: 2401-2405.
2. Skelton JA, Irby MB, Grzywacz JG, et al. Etiologies of obesity in children: nature and nurture. Pediatr Clin North Am 2011; 58: 1333-1354, ix.
3. Bays HE, Gonzalez-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008; 6: 343-368.
4. Yosipovitch G, DeVore A, Dawn A,. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007; 56: 901-916; quiz 917-920.
5. Shipman AR, Millington GW,. Obesity and the skin. Br J Dermatol 2011; 165: 743-750.
6. Scheinfeld NS,. Obesity and dermatology. Clin Dermatol 2004; 22: 303-309.
7. Mathur AN, Goebel L,. Skin findings associated with obesity. Adolesc Med State Art Rev 2011; 22: 146-156, ix.
8. Garcia Hidalgo L,. Dermatological complications of obesity. Am J Clin Dermatol 2002; 3: 497-506.
9. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002; 246: 1-190.
10. Koebnick C, Smith N, Coleman KJ, et al. Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr 2010; 157: 26-31 e22.
11. Kahana M, Grossman E, Feinstein A, et al. Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 1987; 67: 175-177.
12. Brickman WJ, Huang J, Silverman BL, et al. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr 2010; 156: 87-92.
13. 2011 National Diabetes Fact Sheet [online]. http://www.cdc.gov/diabetes/ pubs/pdf/ndfs-2011.pdf. Accessed on February 23, 2012.
14. Hermanns-Lê T, Scheen A, Piérard GE,. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol 2004; 5: 199-203.
15. Tsai MC, Chen W, Cheng YW, et al. Higher body mass index is a significant risk factor for acne formation in schoolchildren. Eur J Dermatol 2006; 16: 251-253.
16. Bourne S, Jacobs A,. Observations on acne, seborrhoea, and obesity. Br Med J 1956; 1: 1268-1270.
17. Lee AT, Zane LT,. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol 2007; 8: 201-219.
18. Nelson LR, Bulun SE,. Estrogen production and action. J Am Acad Dermatol 2001; 45 (Suppl 3): S116-S124.
19. Garcia-Hidalgo L, Orozco-Topete R, Gonzalez-Barranco J, et al. Dermatoses in 156 obese adults. Obes Res 1999; 7: 299-302.
20. Yosipovitch G, Tur E, Cohen O, et al. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care 1993; 16: 560-563.
21. Guida B, Nino M, Perrino NR, et al. The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venereol 2010; 24: 191-195.
22. Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998; 38 (2 Pt 1): 230-239.
23. Shaw TE, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011; 131: 67-73.
24. Silverberg JI, Kleiman E, Lev-Tov H, et al. Association between obesity and atopic dermatitis in childhood: a case-control study. J Allergy Clin Immunol 2011; 127: 1180-1186.
25. Haslund P, Lee RA, Jemec GB,. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 2009; 89: 595-600.
26. Gulliver WP, Jemec GB, Baker KA,. Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2012; 26: 911-914.